Publication

Article

CURE

Summer 2009
Volume8
Issue 2

Program Keeps Tabs on Childhood Cancer Survivors

Author(s):

Childhood cancer survivors find lifelong care at ACE program.

One of only a few programs of its kind in the country, the After the Cancer Experience (ACE) program at UT Southwestern Medical Center and Children’s Medical Center in Dallas provides lifelong follow-up care for survivors of childhood cancer.

Diagnosed with acute lymphocytic leukemia at age 4, Alexandra Wilson, now 18, has yearly checkups at the ACE clinic.

“Every year I come back, they always find new things,” she says. “I’ve had heart problems, and without keeping in contact I never would have known. Even though I’m cured, there are so many side effects of the chemotherapy, you just have to be on top of things.”

Studies show up to two-thirds of childhood cancer survivors will experience a long-term complication as a result of their cancer or its treatment and one-fourth will experience a severe or life-threatening complication. According to the program’s medical director, Dan Bowers, MD, of UT South—western Medical Center, many of these complications don’t arise until several years or decades after treatment.

Childhood cancer survivors are eligible for the ACE program beginning two years after completing treatment. Once they turn 18, they are then seen by Angela Orlino, MD, who is board-certified in both pediatrics and internal medicine. “There is a seamless transition from their care as children at the pediatric hospital through their transition to adulthood,” says Bowers.

Wilson has participated in the ACE program since she went into remission at age 6. “I come back and I know the people every time, and I have this support and relationship with them.”

Survivors are typically seen once a year, although it can vary depending on an individual’s needs and situation. Nearly 2,000 childhood cancer survivors participate in the ACE program and range from 3 to 59 years old.

“That’s just an example of what sets us apart, because many of the survivor programs for children under 18 do not have a counterpart in the adult world,” Bowers says. In addition to the annual checkup, other services include routine screenings for second cancers, education about risk factors and health maintenance, and the opportunity to participate in research studies about the unique problems and needs of childhood cancer survivors.

For more information, visit www.childrens.com/ace or call 214-456-2948.

Related Videos
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
Image of doctor with brown hair.
Image of man with black hair.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Related Content